Scientists strike note of caution as 'Made in India' vaccine programme gains momentum

India's premier medical body ICMR has said 12 clinical trial sites for the indigenous Covaxin, being developed in collaboration with the Hyderabad-based Bharat Biotech and the National Institute of Virology (NIV), have been identified.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/38pKlmB
via IFTTT